The overall goal of the Mayo Clinic CTSA is to continue to build a broad-based and integrated home for clinical and translational science (CTS) at Mayo Clinic that will ultimately improve human health. In this context, we seek to make the Mayo CTSA and the resources it leverages both an engine of efficiency for clinical and translational research and at the same time a driver of innovation. We also seek to integrate our local activities with consortium wide efforts directed at coordination and alignment. To achieve our goal we have six overarching specific aims for this renewal:
Aim 1 - Train and maintain an outstanding multidisciplinary clinical and translational sciences workforce. This workforce includes teams of both investigators and support staff.
Aim 2 - Eliminate barriers to the work of translation. This will be accomplished through a) continued efforts at regulatory and compliance streamlining, b) provision of outstanding design, biostatistics, and ethics support for investigators, and c) further integration of support services.
Aim 3 - Collaborate with providers and communities to improve health care delivery and community health. This includes substantial commitments to practice-based research, communityengaged research and translating comparative effectiveness research into clinical practice.
Aim 4 - Deploy advanced facilities and other core resources to increase the value of clinical research. With value defined in this context as the quotient of quality and cost, the goal is to increase quality, decrease costs, and provide resources to the full spectrum of clinical and translational investigation.
Aim 5 - Stimulate novel research directions and methodologies by targeted support of innovative pilot and feasibility studies and fostering the development of novel methodologies.
Aim 6 - Employ informatics to integrate and facilitate clinical and translational investigation. This encompasses a broad view of informatics including: a) developing a standardized electronic data capture and analysis tools for CTS, b) robust consultation and tools for medical informatics that leverage Mayo's commitments to electronic clinical systems, and c) bioinformatics services and capabilities that will help facilitate the application of the "new biology" to clinical and translational investigation. This vision is entirely consistent with the stated mission of Mayo Clinic: "To provide the best care to every patient every day through integrated clinical practice, education, and research."
Mayo Clinic Center for Translational Science Activities will bring together all the resources of the five schools within the Mayo Clinic College of Medicine and more than 100 years of scientific and medical research expertise, to discover innovative new methods that will speed the translation of research results into therapies, tools, and patient care practices that impact both our local and national communities by improving their health.
|Halverson, Colin Me; Clift, Kristin E; McCormick, Jennifer B (2016) Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine. J Community Genet 7:145-52|
|Patnaik, Mrinal M; Tefferi, Ayalew (2016) Chronic Myelomonocytic Leukemia: Focus on Clinical Practice. Mayo Clin Proc 91:259-72|
|VAN Iterson, Erik H; Snyder, Eric M; Johnson, Bruce D et al. (2016) Influence of the Metaboreflex on Pulmonary Vascular Capacitance in Heart Failure. Med Sci Sports Exerc 48:353-62|
|Renfro, Lindsay A; Zhang, Nan; Lopatin, Margarita et al. (2016) Prospective Evaluation of a 12-Gene Assay on Patient Treatment Decisions and Physician Confidence in Mismatch Repair Proficient Stage IIA Colon Cancer. Clin Colorectal Cancer :|
|Majithia, Neil; Smith, Thomas J; Coyne, Patrick J et al. (2016) Scrambler Therapy for the management of chronic pain. Support Care Cancer 24:2807-14|
|Patnaik, Mrinal M; Lasho, Terra L; Finke, Christy M et al. (2016) Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing. Am J Hematol 91:492-8|
|Tillema, Jan-Mendelt; Weigand, Stephen D; Mandrekar, Jay et al. (2016) In vivo detection of connectivity between cortical and white matter lesions in early MS. Mult Scler :|
|Wan, Siu-Hin; McKie, Paul M; Schirger, John A et al. (2016) Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Pre-Clinical Diastolic Dysfunction (StageÂ BÂ Heart Failure). JACC Heart Fail 4:539-47|
|Choudhry, Asad J; Baghdadi, Yaser M K; Amr, Mahmoud A et al. (2016) Pylephlebitis: a Review of 95 Cases. J Gastrointest Surg 20:656-61|
|Vincent, Ann; Whipple, Mary O; Low, Phillip A et al. (2016) Patients With Fibromyalgia Have Significant Autonomic Symptoms But Modest Autonomic Dysfunction. PM R 8:425-35|
Showing the most recent 10 out of 95 publications